Try a new search

Format these results:

Searched for:

All

Total Results:

532069


Atopic dermatitis Yardstick: a new era of topical and systemic treatments

De Benedetto, Anna; Boguniewicz, Mark; Fonacier, Luz; Silverberg, Jonathan; Abuabara, Katrina; Ong, Peck Y
The atopic dermatitis (AD) Yardstick articles aim to provide an up-to-date review of AD therapy for clinicians. The first two AD Yardstick articles were published in 2018 and 2023. Since the last update, multiple medications have been added to armamentarium of AD. These include roflumilast cream, tapinarof cream, lebrikizumab and nemolizumab. In the current AD Yardstick article, we aim to provide evidence-based information on these new treatments, as well as updated information on previously reviewed therapy. A new feature of the AD Yardstick article is the addition of patient vignettes, which provide practical guide and clinical pearls for clinicians.
PMID: 42229679
ISSN: 1534-4436
CID: 6043802

Antisense-Mediated Gene Therapy Targeting DMPK Restores Cardiac Ion Channel Function and Electrical Stability in Myotonic Dystrophy Type 1

Pierre, Marion; Sourisseau, Fabien; Jauvin, Dominic; Pouliot, Valérie; Carrer, Michele; Jafar-Nejad, Paymaan; Boutjdir, Mohamed; Chahine, Mohamed
BACKGROUND:Myotonic dystrophy type 1 (DM1) is characterized by toxic RNA gain-of-function leading to cardiac conduction defects and life-threatening arrhythmias. Current therapeutic options remain limited. OBJECTIVE:We evaluated the molecular and electrophysiological efficacy of IONIS-486178, an antisense oligonucleotide (ASO) targeting mutant DMPK transcripts in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) generated from a DM1 patient. METHODS:DM1 hiPSC-CMs were treated with IONIS-486178 for 24 hours. Efficacy was assessed via RT-qPCR for DMPK knockdown and splicing analysis, FISH for nuclear foci quantification, western blot for ion channel protein expression, and whole-cell patch-clamp for ionic currents and action potential (AP) characterization. RESULTS:) reduced in DM1 hiPSC-CMs. This electrophysiological rescue correlated with re-expression of the corresponding ion channel proteins. The treatment also normalized AP kinetics and durations and significantly reduced the incidence of arrhythmogenic events. CONCLUSION/CONCLUSIONS:ASO-mediated suppression of DMPK is sufficient to reverse core electrophysiological defects and reduce arrhythmogenic events in a human cellular model of DM1. These findings validate the biological rationale of targeting DMPK to prevent DM1-associated cardiac complications, supporting the continued development of next-generation ASO delivery platforms.
PMID: 42248312
ISSN: 1556-3871
CID: 6044782

Precision, Pragmatism, and Emerging Paradigms in Determining Kidney Filtration Function

Potluri, Vishnu S; Husain, Syed A; Reese, Peter P
PMID: 42240151
ISSN: 1538-3598
CID: 6044352

Can Computed Tomography Hounsfield Units Predict Distal Humerus Fracture Mechanical Complications?

Esper, Garrett W; Kurtz, Jessica L; Vu, Natalie H; Egol, Kenneth A
INTRODUCTION/BACKGROUND:The purpose of this study was to determine whether CT Hounsfield units (HUs) as a proxy for bone quality can predict postoperative mechanical complications following surgical treatment of distal humerus fractures. METHODS:One hundred fifty-three patients with both column distal humerus fractures who underwent surgical fixation at single institution and had complete radiographic data available were included. Radiographic measurements included the HU value from the surgical distal humerus as determined by measuring the metaphyseal/supracondylar at the midaxial/coronal/sagittal CT image an average of 1 cm from the articular surface using a freehand region of interest. Zones with fracture lines and cortical impaction were avoided for all measurements. Postoperative complications recorded were implant failure, nonunion, and acute periprosthetic fracture. Patients with and without complications were statistically compared, and binary logistic regression was done to determine if CT HU measurements from the distal humerus were predictive of complications. RESULTS:Five patients (3.3%) developed five mechanical complications, including peri-prosthetic humerus fracture (one), implant failure (two), and nonunion (two). Patients with mechanical complications were more likely to be current smokers (40% vs. 6.8%, P = 0.010). Otherwise, no difference was observed in demographics or AO/Orthopedic Trauma Association classification between the cohorts. Patients with complications had markedly lower HU in the coronal plane (P = 0.031). Regression analysis found that current smoking was associated with an increased risk of mechanical complications (P = 0.041, OR = 1.102, 95% confidence interval [CI], 1.087 to 1.710), whereas a higher coronal HU was associated with a decreased risk of complications (P = 0.048, OR = 0.973, 95% CI, 0.961 to 0.991). CONCLUSION/CONCLUSIONS:A thorough smoking history and CT HU measurements in the coronal plane may identify patients with poorer bone quality at higher risk for postoperative mechanical complications following distal humerus fracture fixation.
PMID: 42240330
ISSN: 1940-5480
CID: 6044402

Vertebral metastatic disease: A paradigm shift

Nguyen, Annee; Trivedi, Trupti; O'Callaghan, Ellen; Yoo, Seeley; Zachem, Tanner; Ahmed, Ramzy; De La Garza Ramos, Rafael; Charest-Morin, Raphaele; Bilsky, Mark H; Sciubba, Daniel; Clarke, Michelle; Tatsui, Claudio; Shin, John H; Laufer, Ilya; Barzilai, Ori; Gokaslan, Ziya L; Sahgal, Arjun; Weber, Michael; Sullivan, Patricia Leigh Zadnik; Dea, Nicolas; Lazáry, Áron; Mullikin, Trey; Goodwin, C Rory
Vertebral metastatic disease results from many types of cancer and can have a devastating impact on patient mobility, psychological health, quality of life, and ultimately overall patient survival. However, the development of radiotherapy and surgical techniques has rapidly surged in conjunction with ongoing advances in basic science and translational studies. In this review, we discuss the paradigm shift in our understanding of the epidemiology and treatment algorithms for spinal oncology, ranging from preoperative optimization strategies, radiation and surgical techniques, the utilization of molecular markers and targeted therapeutics in medical oncology, and prognostication tools that underscore a new multidisciplinary approach to spinal oncology care.
PMCID:13221133
PMID: 42221982
ISSN: 2632-2498
CID: 6043462

Federal Lobbyist Spending to Influence 340B Drug Pricing Program Policy

Urban, Cooper; Shore, Caroline; Desai, Sunita; Taylor, Lauren
PMCID:13237611
PMID: 42241005
ISSN: 2574-3805
CID: 6044412

An examination of the influence of prefrontal cortical brain stimulation on sexual decision making

Shaw, Michael T; Cingranelli, Leah; Kobryn, Simona; Tavarez, Isabella; Torres-Aragón, Alberto; Balderrama-Durbin, Christina M; Gibb, Brandon E; Charvet, Leigh E; Mattson, Richard E
The goal of this study was to clarify the contribution of prefrontal cortex activity to men's appraisals, affect states, and decision making in the context of hypothetical heterosexual dating scenarios lacking clear consent. Transcranial direct stimulation (tDCS) was applied to the prefrontal cortex to examine whether it would modify and reduce the likelihood of hypothetical dating violence. Participants (n = 102) responded to first-person vignettes wherein a woman responded either ambiguously or with a refusal to their sexual advance. While responding to the vignettes, participants received sham or active tDCS to modulate prefrontal cortex-mediated responding. Neuromodulation interacted with the communication response type of the woman in the vignette (e.g. ambiguous vs. refusal responses) to influence participants' reports of negative affect (F = 9.57, P = 0.002, Cohen's f2
PMCID:13225266
PMID: 42232253
ISSN: 2753-149x
CID: 6043932

Isolated Cranial Tremors: A Reappraisal

Frucht, Steven; Termsarasab, Pichet
Isolated cranial tremors (face tremor, jaw tremor, vocal tremor, and embouchure tremor) are unusual examples of focal tremor disorders. The etiology and treatment of these troublesome and occasionally disabling conditions deserve more attention. In this review, we summarize current knowledge about these disorders and consider their etiologies and treatment approaches. We suggest changes to the current classification system of isolated cranial tremors based on shared phenomenology and treatment response.
PMID: 42235526
ISSN: 1098-9021
CID: 6044132

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

O'Reilly, Eileen M; Wainberg, Zev A; Hendifar, Andrew E; Borad, Mitesh J; Pietrantonio, Filippo; Pant, Shubham; Hammel, Pascal; Cremolini, Chiara; Manji, Gulam A; Oberstein, Paul E; Garrido-Laguna, Ignacio; Springfeld, Christoph; Azad, Nilofer S; Ueno, Makoto; Chui, Stephen Y; Zhang, Ying; Patel, Hina; Lee, Yeonju; Salman, Zeena; Wolpin, Brian M; ,
BACKGROUND:mutations present in more than 90% of cases. Daraxonrasib is an oral RAS(ON) multiselective, tri-complex inhibitor of the active guanosine triphosphate-bound state of mutant and wild-type RAS. METHODS:G12 and overall populations. Safety was also assessed. RESULTS:G12 population was 7.3 months with daraxonrasib and 3.5 months with chemotherapy, and that in the overall population was 7.2 months and 3.6 months, respectively; the hazard ratios were 0.45 and 0.49, respectively (P<0.001 for both comparisons). Adverse events that occurred after the start of treatment were reported in all the patients in the daraxonrasib group and in 97.7% of those in the chemotherapy group; the incidence of adverse events of grade 3 or higher was 61.8% and 69.6%, respectively. Treatment-related adverse events that led to treatment discontinuation occurred in 1.2% of the patients in the daraxonrasib group and in 11.2% of those in the chemotherapy group. CONCLUSIONS:Among patients with previously treated mPDAC, treatment with daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. (Funded by Revolution Medicines; RASolute 302 ClinicalTrials.gov number, NCT06625320.).
PMID: 42223072
ISSN: 1533-4406
CID: 6043482

Carry On, or Cause for Concern? Interpreting Updates to the Low-Risk TAVR Trials [Editorial]

Israeli, Joseph M; Neuburger, Peter J; Pospishil, Liliya
PMID: 42242989
ISSN: 1532-8422
CID: 6044532